COVID-19 Treatments in the Outpatient Setting

Presenters:
Dr. Peter Phillips
Clinical Professor
Division of Infectious Diseases, University of British Columbia
Dr. Junine Toy, PharmD
Senior Manager for the Drug Treatment Program
BC Centre for Excellence in HIV/AIDS
Share this video:
Scroll to Top

The British Columbia Centre for Excellence in HIV/AIDS Laboratory has discontinued gp-41 resistance testing as T-20 (enfuvirtide/Fuzeon) is no longer available in Canada as of March 31, 2025